Hi 

I hope this email finds you well. We are thrilled to announce that MindBio Therapeutics has been nominated for the second year in a row for several prestigious awards at the upcoming Wonderland Conference in Miami this November.

The nominations include:

• MindBio Therapeutics: Company of the Year
• MindBio Therapeutics: B2B Technology Company of the Year
• MindBio Therapeutics: B2C Technology Company of the Year
• Justin Hanka: Hero of the Year
• Justin Hanka: Innovator of the Year

Vote Here!

Moreover, we would also like to extend our congratulations to Dr Suresh Muthukumaraswamy, who with his impressive team is collaborating with MindBio conducting our world first take-home LSD-Microdosing clinical trials and has deservedly been nominated for Academic of the Year and the University of Auckland in New Zealand, where Suresh is an Associate Professor, has been nominated for University of the Year. 

We would be delighted if you would support our terrific team and esteemed academic colleagues by voting in all categories.

You can cast one vote every day until 3 November 2023, Every vote counts!

Vote Here!

Thank you for believing in our vision and being a part of our journey. Let’s continue making strides to improve the world's health and well-being.

Warm regards,

Co-founder

MindBio Therapeutics Corp

CSE:MBIO

Follow Justin Hanka on

LinkedIn: 

https://www.linkedin.com/in/justinhanka/

To learn more about MindBio go here

https://www.mindbiotherapeutics.com/